
    
      This is an open label, randomized, 6 parallel-group clinical study evaluating changes in
      exposure to selected HPHCs, subjective effects, and product use behavior in adult smokers
      relative to continued smoking who are randomly assigned to continue smoking, partially or
      completely switch to oral tobacco-derived nicotine products, or stop using any tobacco
      products for 7 days.
    
  